Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures

Fertility and Sterility

Volumn 86, Issue 3, 2006, Pages 636-641

  Asimakopoulos, Byron ^a   Nikolettos, Nikos ^a   Nehls, Barbara ^b   Diedrich, Klaus ^b   Al Hasani, Safaa ^b   Metzen, Eric ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

estradiol; GnRH analogues; granulosa cells; progesterone; VEGF

Indexed keywords

CETRORELIX; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN; PROGESTERONE; STEROID HORMONE; VASCULOTROPIN;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; LUTEINIZATION; OVARY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEROID RELEASE; STEROIDOGENESIS; SUPERNATANT; UNIVERSITY HOSPITAL;

ADULT; CELLS, CULTURED; FEMALE; GONADAL STEROID HORMONES; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LUTEINIZATION; OVULATION INDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748119126     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.01.046     Document Type: Article

References (35)

1. Ferrara N., Chen H., Davis-Smyth T., Gerber H.P., Nguyen T.N., Peers D., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4 (1998) 336-340
2. Geva E., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74 (2000) 429-438
3. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Rev 25 (2004) 581-611
4. Tamanini C., and De Ambrogi M. Angiogenesis in developing follicle and corpus luteum. Reprod Dom Anim 39 (2004) 206-216
5. Neulen J., Raczek S., Pogorzelski M., Grunwald K., Yeo T.K., Dvorak H.F., et al. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol Hum Reprod 4 (1998) 203-206
6. Hazzard T.M., Molskness T.A., Chaffin C.L., and Stouffer R.L. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 5 (1999) 1115-1121
7. Molskness T.A., Stouffer R.L., Burry K.A., Gorrill M.J., Lee D.M., and Patton P.E. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum Reprod 19 (2004) 822-830
8. Rizk B., Aboulghar M., Smitz J., and Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update 3 (1997) 255-266
9. Felberbaum R., Reissmann T., Küpker W., Al-Hasani S., Bauer O., Schill T., et al. Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. J Assist Reprod Genet 13 (1996) 216-222
10. Diedrich K., and Felberbaum R. New approaches to ovarian stimulation. Hum Reprod 13 (1998) 1s-13s
11. Felberbaum R.E., Albano C., Ludwig M., Riethmüller-Winzen H., Grigat M., Devroey P., et al. Controlled ovarian stimulation for assisted reproduction with hMG and concomitant midcycle administration of the LHRH-antagonist Cetrorelix (Cetrotide) according to the multiple dose protocol - results of a prospective non controlled phase III study. Hum Reprod 15 (2000) 1015-1020
12. Ludwig M., Felberbaum R.E., and Diedrich K. Interactions of GnRH analogues and gonadotrophins. In: Adashi E.Y., Baird D.T., and Crosignani P.G. (Eds). Gonadotrophins and fertility Vol. 1 (1999), Christengraf, Rome 125-143
13. Ludwig M., Felberbaum R.E., Devroy P., Albano C., Riethmüller-Winzen H., Schüler A., et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 264 (2000) 29-32
14. Ludwig M., Katalinic A., and Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet 265 (2001) 175-182
15. Al-Inany H., and Aboulghar M. GnRH-antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17 (2002) 874-885
16. Hernandez E.R. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 15 (2000) 1211-1216
17. Casper R.F., Erickson G.F., Rebar R.W., and Yen S.S. The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells. Fertil Steril 37 (1982) 406-409
18. Parinaud J., Beaur A., Bourreau E., Vieitez G., and Pontonnier G. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril 50 (1988) 597-602
19. Lanzone A., Panetta V., Di Simone N., Arno E., Fulghesu A.M., Caruso A., et al. Effect of gonadotrophin-releasing hormone and related analogue on human luteal cell function in vitro. Hum Reprod 4 (1989) 906-909
20. Pellicer A., and Miro F. Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with gonadotropin-releasing hormone analogs. Fertil Steril 54 (1990) 590-596
21. Miro F., Sampaio M.C., Tarin J.J., and Pellicer A. Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with two gonadotropin releasing hormone analogs employing different protocols. Gynecol Endocrinol 6 (1992) 77-84
22. Guerrero H.E., Stein P., Asch R.H., de Fried E.P., and Tesone M. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil Steril 59 (1993) 803-808
23. Bussenot I., Azoulay Barjonet C., and Parinaud J. Modulation of the steroidogenesis of cultured human granulosa lutein cells by gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 76 (1993) 1376-1379
24. Gaetje R. Influence of gonadotropin releasing hormone (GnRH) and a GnRH-agonist on granulosa cell steroidogenesis. Clin Exp Obstet Gynecol 21 (1994) 164-169
25. Uemura T., Namiki T., Kimura A., Yanagisawa T., and Minaguchi H. Direct effects of gonadotropin-releasing hormone on the ovary in rats and humans. Horm Res 41 (1994) 7s-13s
26. Minaretzis D., Alper M.M., Oskowitz S.P., Lobel S.M., Mortola J.F., and Pavlou S.N. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: Cycle performance and in-vitro steroidogenesis of granulosa-lutein cells. Am J Obstet Gynecol 172 (1995) 1518-1525
27. Lin Y., Kahn J.A., and Hillenjo T. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?. Hum Reprod 14 (1999) 885-888
28. Weiss J.M., Oltmanns K., Gürke E.M., Polack S., Eick F., Felberbaum R., et al. Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. Eur J Endocrinol 144 (2001) 677-685
29. Weiss J.M., Krautmacher B., Polack S., Diedrich K., and Ortmann O. Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells. Eur J Endocrinol 149 (2003) 31-37
30. Cunha-Filho J.S., Lemos N., Stein N., Laranjeira A., and Passo E.P. Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist. Fertil Steril 83 (2005) 902-907
31. Sealfon S.C., Weinstein H., and Millar R.P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev 18 (1997) 180-205
32. Millar R.P., Lu Z.-L., Pawson A.J., Flanagan C.A., Morgan K., and Maudsley S.R. Gonadotropin-releasing hormone receptors. Endocr Rev 25 (2004) 235-275
33. Millar R.P., and Pawson A.J. Outside-in and inside-out signalling: the new concept that selectivity of ligand binding at the gonadotropin-releasing hormone receptor is modulated by the intracellular environment. Endocrinology 145 (2004) 3590-3593
34. Millar R., Pawson A., Lu Z.-L., Morgan K., Davidson L., Lopez de Maturana R., et al. New concepts in GnRH receptor function. In: Filicori M. (Ed). Updates in infertility treatment 2004 (2004), Medimont Srl, Bologna, Italy 51-64
35. Gründker C., Naor Z., Millar R.P., Seger R., Leung P.C., and Emons G. Mechanisms of action of GnRH. In: Lunenfeld B. (Ed). GnRH analogs in human reproduction (2005), Taylor & Francis Group, London and New York 1-34